AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+7.64%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$17.2B
AUM Growth
+$1.4B
(+8.8%)
Cap. Flow
+$551M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
62.73%
Holding
1,140
New
150
Increased
453
Reduced
383
Closed
150
Top Buys
| 1 |
Hess Midstream
HESM
|
$264M |
| 2 |
Energy Transfer Partners
ET
|
$160M |
| 3 |
Sunoco
SUN
|
$147M |
| 4 |
Western Midstream Partners
WES
|
$98.3M |
| 5 |
Cheniere Energy
CQP
|
$84.8M |
Top Sells
| 1 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
$706M |
| 2 |
Cameco
CCJ
|
$27.3M |
| 3 |
Fortuna Silver Mines
FSM
|
$12M |
| 4 |
MPLX
MPLX
|
$11.6M |
| 5 |
CVS Health
CVS
|
$8.33M |
Sector Composition
| 1 | Energy | 69.95% |
| 2 | Technology | 3.96% |
| 3 | Financials | 3.32% |
| 4 | Consumer Discretionary | 3% |
| 5 | Utilities | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONL
951
Orion Office REIT
ONL
$168M
| $240K | ﹤0.01% |
112,115
+34,755
| +45% | +$74.4K |
|
952
Amylyx Pharmaceuticals
AMLX
$871M
| $239K | ﹤0.01% |
67,597
+12,167
| +22% | +$43.1K |
|
|
UPB
953
Upstream Bio, Inc. Common Stock
UPB
$1.05B
| $239K | ﹤0.01% |
39,079
-4,261
| -10% | -$26.1K |
|
954
Rigel Pharmaceuticals
RIGL
$728M
| $236K | ﹤0.01% |
13,100
-1,140
| -8% | -$20.5K |
|
955
Astria Therapeutics
ATXS
$423M
| $232K | ﹤0.01% |
43,444
-2,186
| -5% | -$11.7K |
|
|
ZBIO
956
Zenas BioPharma, Inc. Common Stock
ZBIO
$798M
| $222K | ﹤0.01% |
28,132
-5,658
| -17% | -$44.7K |
|
957
Aura Biosciences
AURA
$404M
| $218K | ﹤0.01% |
37,156
-3,236
| -8% | -$19K |
|
|
PLL
958
DELISTED
Piedmont Lithium
PLL
| $212K | ﹤0.01% |
33,637
+17,097
| +103% | +$108K |
|
959
Arcturus Therapeutics
ARCT
$491M
| $211K | ﹤0.01% |
19,949
-1,952
| -9% | -$20.7K |
|
960
Innovative Industrial Properties
IIPR
$1.6B
| $209K | ﹤0.01% |
+3,868
| New | +$209K |
|
|
RC
961
Ready Capital
RC
$707M
| $195K | ﹤0.01% |
38,398
-1,396
| -4% | -$7.11K |
|
962
Vanda Pharmaceuticals
VNDA
$274M
| $193K | ﹤0.01% |
41,993
-5,156
| -11% | -$23.7K |
|
|
MBX
963
MBX Biosciences, Inc. Common Stock
MBX
$395M
| $192K | ﹤0.01% |
26,034
-986
| -4% | -$7.28K |
|
964
Olema Pharmaceuticals
OLMA
$559M
| $190K | ﹤0.01% |
50,484
+4,149
| +9% | +$15.6K |
|
|
CMPS
965
Compass Pathways
CMPS
$478M
| $189K | ﹤0.01% |
66,231
+10,899
| +20% | +$31.2K |
|
|
SLRN
966
DELISTED
ACELYRIN
SLRN
| $184K | ﹤0.01% |
74,640
-6,489
| -8% | -$16K |
|
967
Ironwood Pharmaceuticals
IRWD
$187M
| $172K | ﹤0.01% |
116,860
-12,537
| -10% | -$18.4K |
|
|
ITOS
968
DELISTED
iTeos Therapeutics
ITOS
| $171K | ﹤0.01% |
28,646
-894
| -3% | -$5.34K |
|
|
ASM
969
Avino Silver & Gold Mines
ASM
$629M
| $169K | ﹤0.01% |
92,088
+38,002
| +70% | +$69.9K |
|
970
Annexon
ANNX
$240M
| $159K | ﹤0.01% |
82,626
-3,568
| -4% | -$6.89K |
|
971
Eledon Pharmaceuticals
ELDN
$168M
| $151K | ﹤0.01% |
44,436
-3,874
| -8% | -$13.1K |
|
972
Y-mAbs Therapeutics
YMAB
$389M
| $148K | ﹤0.01% |
33,309
-2,906
| -8% | -$12.9K |
|
973
SITE Centers
SITC
$492M
| $136K | ﹤0.01% |
10,629
-386
| -4% | -$4.96K |
|
|
CRGX
974
DELISTED
CARGO Therapeutics
CRGX
| $135K | ﹤0.01% |
33,158
-4,064
| -11% | -$16.5K |
|
975
Rezolute
RZLT
$683M
| $125K | ﹤0.01% |
43,086
-3,764
| -8% | -$10.9K |
|